{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:11:31Z","timestamp":1790946691827,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"Genzyme Gaucher","award":["GZ-2011-10810"],"award-info":[{"award-number":["GZ-2011-10810"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.gene.2018.08.045","type":"journal-article","created":{"date-parts":[[2018,8,9]],"date-time":"2018-08-09T16:55:50Z","timestamp":1533833750000},"page":"196-206","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Generation of osteoclasts from type 1 Gaucher patients and correlation with clinical and genetic features of disease"],"prefix":"10.1016","volume":"678","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9338-7843","authenticated-orcid":false,"given":"Matthew C.","family":"Reed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehudit","family":"Bauernfreund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niamh","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan","family":"Beaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul B.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derralynn A.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.gene.2018.08.045_bb0005","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/qjmed\/90.1.19","article-title":"Pro-inflammatory cytokines and the pathogenesis of Gaucher's disease: increased release of interleukin-6 and interleukin-10","volume":"90","author":"Allen","year":"1997","journal-title":"QJM"},{"issue":"6","key":"10.1016\/j.gene.2018.08.045_bb0010","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s00277-017-2959-0","article-title":"Bone quality in beta-thalassemia intermedia: relationships with bone quantity and endocrine and hematologic variables","volume":"96","author":"Baldini","year":"2017","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.gene.2018.08.045_bb0015","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.bcmd.2015.05.003","article-title":"Re-evaluation of bone pain in patients with type 1 Gaucher disease suggests that bone crises occur in small bones as well as long bones","volume":"60","author":"Baris","year":"2016","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.gene.2018.08.045_bb0020","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.bone.2017.07.020","article-title":"In vitro osteoclastogenesis from Gaucher patients' cells correlates with bone mineral density but not with Chitotriosidase","volume":"103","author":"Bondar","year":"2017","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.gene.2018.08.045_bb0025","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1182\/blood-2003-05-1612","article-title":"Marked elevation of the chemokine CCL18\/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention","volume":"103","author":"Boot","year":"2004","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.gene.2018.08.045_bb0030","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1309\/BG5VA8JRDQH1M7HN","article-title":"Gaucher cells demonstrate a distinct macrophage phenotype and resemble alternatively activated macrophages","volume":"122","author":"Boven","year":"2004","journal-title":"Am. J. Clin. Pathol."},{"issue":"7","key":"10.1016\/j.gene.2018.08.045_bb0035","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1172\/JCI105417","article-title":"Demonstration of a deficiency of glucocerebroside-cleaving enzyme in Gaucher's disease","volume":"45","author":"Brady","year":"1966","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.gene.2018.08.045_bb0040","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.bbadis.2007.04.002","article-title":"Increased plasma macrophage inflammatory protein (MIP)-1alpha and MIP-1beta levels in type 1 Gaucher disease","volume":"1772","author":"van Breemen","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.gene.2018.08.045_bb0045","first-page":"149","article-title":"Abnormalities of cellular immunity and natural killer cells in Gaucher's disease","volume":"23","author":"Burstein","year":"1987","journal-title":"J. Clin. Lab. Immunol."},{"issue":"18","key":"10.1016\/j.gene.2018.08.045_bb0050","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1001\/archinte.160.18.2835","article-title":"The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease","volume":"160","author":"Charrow","year":"2000","journal-title":"Arch. Intern. Med."},{"issue":"12","key":"10.1016\/j.gene.2018.08.045_bb0055","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1111\/j.1532-5415.2010.03183.x","article-title":"The relationship between incidence of fractures and anemia in older multiethnic women","volume":"58","author":"Chen","year":"2010","journal-title":"J. Am. Geriatr. Soc."},{"issue":"3","key":"10.1016\/j.gene.2018.08.045_bb0060","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00223-001-2072-0","article-title":"Bone marker alterations in patients with type 1 Gaucher disease","volume":"72","author":"Ciana","year":"2003","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.gene.2018.08.045_bb0065","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s10545-005-0032-y","article-title":"Gaucher disease and bone: laboratory and skeletal mineral density variations during a long period of enzyme replacement therapy","volume":"28","author":"Ciana","year":"2005","journal-title":"J. Inherit. Metab. Dis."},{"issue":"2","key":"10.1016\/j.gene.2018.08.045_bb0070","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.beem.2014.08.010","article-title":"The clinical spectrum and pathophysiology of skeletal complications in lysosomal storage disorders","volume":"29","author":"Clarke","year":"2015","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.gene.2018.08.045_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuint.2012.10.010","article-title":"Glucocerebrosidase inhibition causes mitochondrial dysfunction and free radical damage","volume":"62","author":"Cleeter","year":"2013","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.gene.2018.08.045_bb0080","first-page":"299","article-title":"Gaucher disease: clinical profile and therapeutic developments","volume":"4","author":"Cox","year":"2010","journal-title":"Biologics"},{"issue":"4","key":"10.1016\/j.gene.2018.08.045_bb0085","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0950-3536(97)80033-9","article-title":"Gaucher's disease: clinical features and natural history","volume":"10","author":"Cox","year":"1997","journal-title":"Baillieres Clin. Haematol."},{"issue":"1","key":"10.1016\/j.gene.2018.08.045_bb0090","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/MD.0b013e3182057be4","article-title":"Osseous manifestations of adult Gaucher disease in the era of enzyme replacement therapy","volume":"90","author":"Deegan","year":"2011","journal-title":"Medicine"},{"issue":"10","key":"10.1016\/j.gene.2018.08.045_bb0095","doi-asserted-by":"crossref","first-page":"E448","DOI":"10.1002\/ajh.24486","article-title":"Skeletal involvement in Gaucher disease: an observational multicenter study of prognostic factors in the Argentine Gaucher disease patients","volume":"91","author":"Drelichman","year":"2016","journal-title":"Am. J. Hematol."},{"issue":"1","key":"10.1016\/j.gene.2018.08.045_bb0100","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1006\/bcmd.2001.0479","article-title":"Biochemical markers of bone turnover as tools in the evaluation of skeletal involvement in patients with type 1 Gaucher disease","volume":"28","author":"Drugan","year":"2002","journal-title":"Blood Cells Mol. Dis."},{"issue":"7","key":"10.1016\/j.gene.2018.08.045_bb0105","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1210\/jc.2011-0162","article-title":"Markers of bone turnover in Gaucher disease: modeling the evolution of bone disease","volume":"96","author":"van Dussen","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.gene.2018.08.045_bb0110","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s10545-014-9711-x","article-title":"Value of plasma chitotriosidase to assess non-neuronopathic Gaucher disease severity and progression in the era of enzyme replacement therapy","volume":"37","author":"van Dussen","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.gene.2018.08.045_bb0115","first-page":"30","article-title":"Pamidronate effect compared with a steroid on complex regional pain syndrome type I: pilot randomised trial","volume":"74","author":"Eun Young","year":"2016","journal-title":"Neth. J. Med."},{"issue":"7","key":"10.1016\/j.gene.2018.08.045_bb0120","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.3324\/haematol.12651","article-title":"Persistent bone disease in adult type 1 Gaucher disease despite increasing doses of enzyme replacement therapy","volume":"93","author":"de Fost","year":"2008","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.gene.2018.08.045_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126153","article-title":"The influence of genetic variability and proinflammatory status on the development of bone disease in patients with Gaucher disease","volume":"10","author":"Gervas-Arruga","year":"2015","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.gene.2018.08.045_bb0130","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1007\/s00198-009-1131-7","article-title":"Anemia and the risk of non-vertebral fractures: the Troms\u00f8 study","volume":"21","author":"J\u00f8rgensen","year":"2010","journal-title":"Osteoporos. Int."},{"issue":"8","key":"10.1016\/j.gene.2018.08.045_bb0135","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1002\/jbmr.1680","article-title":"Risk factors for fractures and avascular osteonecrosis in type 1 Gaucher disease: a study from the International Collaborative Gaucher Group (ICGG) Gaucher Registry","volume":"27","author":"Khan","year":"2012","journal-title":"J. Bone Miner. Res."},{"issue":"2","key":"10.1016\/j.gene.2018.08.045_bb0140","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ejim.2011.11.009","article-title":"Anemia as a risk factor for low bone mineral density in postmenopausal Turkish women","volume":"23","author":"Korkmaz","year":"2012","journal-title":"Eur. J. Intern. Med."},{"issue":"7","key":"10.1016\/j.gene.2018.08.045_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069293","article-title":"A prospective study of bone marrow hematopoietic and mesenchymal stem cells in type 1 Gaucher disease patients","volume":"8","author":"Lecourt","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.gene.2018.08.045_bb0150","first-page":"157","article-title":"Clinical manifestations and management of Gaucher disease","volume":"12","author":"Linari","year":"2015","journal-title":"Clin. Cases Miner. Bone Metab."},{"issue":"Suppl. 1","key":"10.1016\/j.gene.2018.08.045_bb0155","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1259\/bjr.75.suppl_1.750013","article-title":"Imaging and quantifying skeletal involvement in Gaucher disease","volume":"75","author":"Maas","year":"2002","journal-title":"Br. J. Radiol."},{"issue":"1","key":"10.1016\/j.gene.2018.08.045_bb0160","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1023\/A:1005655031239","article-title":"The natural course of Gaucher disease in The Netherlands: implications for monitoring of disease manifestations","volume":"23","author":"Maaswinkel-Mooij","year":"2000","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.gene.2018.08.045_bb0165","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2214\/AJR.07.3550","article-title":"Correlation of MRI-based bone marrow burden score with genotype and spleen status in Gaucher's disease","volume":"191","author":"de Mayo","year":"2008","journal-title":"AJR Am. J. Roentgenol."},{"issue":"45","key":"10.1016\/j.gene.2018.08.045_bb0170","doi-asserted-by":"crossref","first-page":"19473","DOI":"10.1073\/pnas.1003308107","article-title":"Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage","volume":"107","author":"Mistry","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.gene.2018.08.045_bb0175","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bcmd.2010.10.011","article-title":"Osteopenia in Gaucher disease develops early in life: response to imiglucerase enzyme therapy in children, adolescents and adults","volume":"46","author":"Mistry","year":"2011","journal-title":"Blood Cells Mol. Dis."},{"issue":"8","key":"10.1016\/j.gene.2018.08.045_bb0180","doi-asserted-by":"crossref","first-page":"590","DOI":"10.5312\/wjo.v6.i8.590","article-title":"Current concepts on osteonecrosis of the femoral head","volume":"6","author":"Moya-Angeler","year":"2015","journal-title":"World J. Orthop."},{"issue":"1433","key":"10.1016\/j.gene.2018.08.045_bb0185","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1098\/rstb.2003.1271","article-title":"Substrate reduction therapy: clinical evaluation in type 1 Gaucher disease","volume":"358","author":"Moyses","year":"2003","journal-title":"Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci."},{"issue":"2","key":"10.1016\/j.gene.2018.08.045_bb0190","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.gene.2013.09.072","article-title":"Uncoupling of osteoblast-osteoclast regulation in a chemical murine model of Gaucher disease","volume":"532","author":"Mucci","year":"2013","journal-title":"Gene"},{"issue":"11","key":"10.1016\/j.gene.2018.08.045_bb0195","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/ajh.24491","article-title":"Glucosylsphingosine is a key biomarker of Gaucher disease","volume":"91","author":"Murugesan","year":"2016","journal-title":"Am. J. Hematol."},{"issue":"7643","key":"10.1016\/j.gene.2018.08.045_bb0200","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature21368","article-title":"Grabowski GA1. Complement drives glucosylceramide accumulation and tissue inflammation in Gaucher disease","volume":"543","author":"Pandey","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.gene.2018.08.045_bb0205","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.pain.2013.09.016","article-title":"A pilot trial of intravenous pamidronate for chronic low back pain","volume":"155","author":"Pappagallo","year":"2014","journal-title":"Pain"},{"issue":"11","key":"10.1016\/j.gene.2018.08.045_bb0210","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1002\/jbmr.5650111125","article-title":"Bone density in type 1 Gaucher disease","volume":"11","author":"Pastores","year":"1996","journal-title":"J. Bone Miner. Res."},{"issue":"2","key":"10.1016\/j.gene.2018.08.045_bb0215","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1006\/bcmd.2002.0511","article-title":"Correlation of bone marrow response with hematological, biochemical, and visceral responses to enzyme replacement therapy of nonneuronopathic (type 1) Gaucher disease in 30 adult patients","volume":"28","author":"Poll","year":"2002","journal-title":"Blood Cells Mol. Dis."},{"issue":"3","key":"10.1016\/j.gene.2018.08.045_bb0220","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.bcmd.2013.04.006","article-title":"Enhanced differentiation of osteoclasts from mononuclear precursors in patients with Gaucher disease","volume":"51","author":"Reed","year":"2013","journal-title":"Blood Cells Mol. Dis."},{"issue":"6","key":"10.1016\/j.gene.2018.08.045_bb0225","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0021-9258(18)49334-9","article-title":"A reinvestigation of the cerebroside deposited in Gaucher's disease","volume":"233","author":"Rosenberg","year":"1958","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.gene.2018.08.045_bb0230","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1006\/bcmd.2002.0517","article-title":"Decreased bone density in splenectomized Gaucher patients receiving enzyme replacement therapy","volume":"28","author":"Schiffmann","year":"2002","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.gene.2018.08.045_bb0235","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1399-0004.2008.00978.x","article-title":"Improvement of bone disease by imiglucerase (Cerezyme) therapy in patients with skeletal manifestations of type 1 Gaucher disease: results of a 48-month longitudinal cohort study","volume":"73","author":"Sims","year":"2008","journal-title":"Clin. Genet."},{"key":"10.1016\/j.gene.2018.08.045_bb0240","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/8904_2014_357","article-title":"Severe impairment of regulatory T-cells and Th1-lymphocyte polarization in patients with Gaucher disease","volume":"18","author":"Sotiropoulos","year":"2015","journal-title":"JIMD Rep."},{"issue":"5","key":"10.1016\/j.gene.2018.08.045_bb0245","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/00005792-198509000-00003","article-title":"Skeletal complications of Gaucher disease","volume":"64","author":"Stowens","year":"1985","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.gene.2018.08.045_bb2000","doi-asserted-by":"crossref","first-page":"R156","DOI":"10.1186\/ar3111","article-title":"Bone events and evolution of biologic markers in Gaucher disease before and during treatment","volume":"12","author":"Stirnemann","year":"2010","journal-title":"Arthritis Res. Ther."},{"issue":"5","key":"10.1016\/j.gene.2018.08.045_bb0250","article-title":"Bone microstructure and regional distribution of osteoblast and osteoclast activity in the osteonecrotic femoral head","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.gene.2018.08.045_bb0255","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0002-9343(02)01150-6","article-title":"Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5\u202fyears of treatment: a report from the Gaucher Registry","volume":"113","author":"Weinreb","year":"2002","journal-title":"Am. J. Med."}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111918309077?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111918309077?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T18:44:01Z","timestamp":1717267441000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111918309077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":52,"alternative-id":["S0378111918309077"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2018.08.045","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Generation of osteoclasts from type 1 Gaucher patients and correlation with clinical and genetic features of disease","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2018.08.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}